
Sign up to save your podcasts
Or


Send us Fan Mail
Welcome back Rounds Table Listeners! We are back today with a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the safety and efficacy of lorundrostat (an aldosterone synthase inhibitor) in treatment of uncontrolled and treatment-resistant hypertension. Here we go!
The Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods
By Dr. John Fralick and Dr. Michael Fralick5
1212 ratings
Send us Fan Mail
Welcome back Rounds Table Listeners! We are back today with a solo episode with Dr. Mike Fralick. This week, he discusses a recently published trial exploring the safety and efficacy of lorundrostat (an aldosterone synthase inhibitor) in treatment of uncontrolled and treatment-resistant hypertension. Here we go!
The Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable @InternAtWork @MedicinePods

91,297 Listeners

43,837 Listeners

321 Listeners

549 Listeners

701 Listeners

504 Listeners

3,374 Listeners

1,150 Listeners

68 Listeners

518 Listeners

367 Listeners

260 Listeners

320 Listeners

11,013 Listeners

4,294 Listeners